https://peptidechooser.com/fda-warning-letters/New FDA warning letters to peptide sellers, compounders and online clinics, with a link to each letter on fda.gov.en-usMon, 02 Nov 2026 00:00:00 +0000https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cheap-medicine-shopwwwcheapmedicineshopcom-737810-09242026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cheap-medicine-shopwwwcheapmedicineshopcom-737810-09242026Thu, 24 Sep 2026 00:00:00 +000024 Sep 2026. Cheap Medicine Shop/www.cheapmedicineshop.com. Unapproved New Drugs/Misbranded (Internet Pharmacy). Center for Drug Evaluation and Research (CDER).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/online-generic-medicinewwwonlinegenericmedicinecom-737806-09232026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/online-generic-medicinewwwonlinegenericmedicinecom-737806-09232026Wed, 23 Sep 2026 00:00:00 +000023 Sep 2026. Online Generic Medicine/www.onlinegenericmedicine.com. Unapproved New Drug/Misbranded (Internet Pharmacy). Center for Drug Evaluation and Research (CDER).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026Fri, 18 Sep 2026 00:00:00 +000018 Sep 2026. Empower Clinic Services, LLC dba Empower Pharmacy. CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug. Center for Drug Evaluation and Research (CDER).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nuscience-peptides-llc-733652-08242026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nuscience-peptides-llc-733652-08242026Mon, 24 Aug 2026 00:00:00 +000024 Aug 2026. NuScience Peptides LLC. Unapproved New Drugs/Misbranded. Center for Drug Evaluation and Research (CDER). In our database: NuScience Peptides LLC.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peak-performance-peptides-735127-08242026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peak-performance-peptides-735127-08242026Mon, 24 Aug 2026 00:00:00 +000024 Aug 2026. Peak Performance Peptides. Unapproved New Drugs/Misbranded. Center for Drug Evaluation and Research (CDER). In our database: Peak Performance Peptides.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peptide-partners-llc-735063-08242026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peptide-partners-llc-735063-08242026Mon, 24 Aug 2026 00:00:00 +000024 Aug 2026. Peptide Partners LLC. Unapproved New Drugs/Misbranded. Center for Drug Evaluation and Research (CDER). In our database: Peptide Partners LLC (Pirsek Technologies LLC).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/royal-peptides-llc-734884-08242026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/royal-peptides-llc-734884-08242026Mon, 24 Aug 2026 00:00:00 +000024 Aug 2026. Royal Peptides LLC. Unapproved New Drugs/Misbranded. Center for Drug Evaluation and Research (CDER). In our database: Royal Peptides LLC.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/txp-innovations-llc-dba-tex-peptides-735067-08242026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/txp-innovations-llc-dba-tex-peptides-735067-08242026Mon, 24 Aug 2026 00:00:00 +000024 Aug 2026. TXP Innovations LLC dba Tex Peptides. Unapproved New Drugs/Misbranded. Center for Drug Evaluation and Research (CDER). In our database: Tex Peptides (TXP Innovations LLC).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wholesale-peptide-729447-06172026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wholesale-peptide-729447-06172026Wed, 17 Jun 2026 00:00:00 +000017 Jun 2026. Wholesale Peptide. Unapproved New Drugs/Misbranded. Center for Drug Evaluation and Research (CDER). In our database: Wholesale Peptide.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/altru-telehealth-llc-dba-altru-telehealth-728274-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/altru-telehealth-llc-dba-altru-telehealth-728274-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Altru Telehealth, LLC dba Altru Telehealth. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Altru Telehealth.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amie-health-inc-dba-amie-728276-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amie-health-inc-dba-amie-728276-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Amie Health, Inc. dba Amie. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Amie.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/clover-meds-llc-dba-clover-meds-728234-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/clover-meds-llc-dba-clover-meds-728234-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Clover Meds LLC dba Clover Meds. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Clover Meds.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dh-medical-services-728238-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dh-medical-services-728238-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. D&H Medical Services. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: D&H Medical Services.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eden-health-international-inc-dba-eden-728279-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eden-health-international-inc-dba-eden-728279-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Eden Health International Inc. dba Eden. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Eden (Eden Health International Inc.).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ezra-holdco-llc-dba-ezra-730995-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ezra-holdco-llc-dba-ezra-730995-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Ezra Holdco LLC dba Ezra. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Ezra.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitish-728280-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitish-728280-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. FITISH. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: FITISH.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-am-rx-728275-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-am-rx-728275-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. FitRX, LLC dba AM RX. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Zealthy (FitRX, LLC; also dba FitRx and AM RX).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glow-medispa-llc-dba-mint-med-730390-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glow-medispa-llc-dba-mint-med-730390-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Glow Medispa, LLC dba Mint Med. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Mint Med.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hydramed-iv-llc-dba-hydramed-728282-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hydramed-iv-llc-dba-hydramed-728282-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. HydraMed IV LLC dba HydraMed. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: HydraMed.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/joi-and-blokes-dba-joi-blokes-728283-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/joi-and-blokes-dba-joi-blokes-728283-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Joi and Blokes dba Joi + Blokes. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Joi + Blokes.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maximus-health-inc-dba-maximus-730095-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maximus-health-inc-dba-maximus-730095-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Maximus Health, Inc. dba Maximus. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Maximus (Maximus Health, Inc.).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medica-weight-loss-728284-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medica-weight-loss-728284-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Medica Weight Loss. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Medica Weight Loss.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/momentum-health-360-dba-momentum-health-728286-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/momentum-health-360-dba-momentum-health-728286-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Momentum Health 360 dba Momentum Health. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Momentum Health.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nativemed-llc-dba-nativemed-728287-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nativemed-llc-dba-nativemed-728287-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. NativeMed LLC dba NativeMed. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: NativeMed.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nexlife-inc-dba-nexlife-730096-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nexlife-inc-dba-nexlife-730096-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Nexlife Inc. dba Nexlife. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Nexlife.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nexus-health-solutions-llc-dba-harper-meds-728281-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nexus-health-solutions-llc-dba-harper-meds-728281-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Nexus Health Solutions LLC dba Harper Meds. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Harper Meds (Nexus Health Solutions LLC).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nova-vascular-llc-dba-novarx-728290-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nova-vascular-llc-dba-novarx-728290-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Nova Vascular LLC dba NOVARX. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: NOVARX.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/orderlymeds-llc-dba-orderlymeds-728291-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/orderlymeds-llc-dba-orderlymeds-728291-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. OrderlyMeds LLC dba OrderlyMeds. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: OrderlyMeds.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/public-health-solution-llc-dba-drmedhealth-728278-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/public-health-solution-llc-dba-drmedhealth-728278-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Public Health Solution LLC dba DrMedHealth. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: DrMedHealth.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ready-med-730317-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ready-med-730317-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Ready Med. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Ready Med.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/roen-health-inc-dba-roenrx-728293-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/roen-health-inc-dba-roenrx-728293-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Roen Health, Inc. dba RoenRx. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: RoenRx.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/thrivelab-co-dba-thrivelab-728294-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/thrivelab-co-dba-thrivelab-728294-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Thrivelab Co. dba Thrivelab. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Thrivelab (Thrivelab Co.).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trinity-healthcare-supply-llc-dba-altrx-728236-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trinity-healthcare-supply-llc-dba-altrx-728236-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. Trinity HealthCare Supply, LLC dba altRx. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: altRx (Trinity HealthCare Supply, LLC).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/viviomd-group-llc-dba-viviomd-728295-06082026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/viviomd-group-llc-dba-viviomd-728295-06082026Mon, 08 Jun 2026 00:00:00 +00008 Jun 2026. VivioMD Group LLC dba VivioMD. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: VivioMD (VivioMD Group LLC).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/harbin-jixianglong-biotech-co-ltd-723330-05012026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/harbin-jixianglong-biotech-co-ltd-723330-05012026Fri, 01 May 2026 00:00:00 +00001 May 2026. Harbin Jixianglong Biotech Co., Ltd.. CGMP/API/Adulterated and Misbranded Drugs. Center for Drug Evaluation and Research (CDER).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/new-life-pharma-llc-725661-04142026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/new-life-pharma-llc-725661-04142026Tue, 14 Apr 2026 00:00:00 +000014 Apr 2026. New Life Pharma LLC. CGMP/Adulterated and Unapproved New Drug/Misbranded. Center for Drug Evaluation and Research (CDER).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/prorx-llc-723704-04072026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/prorx-llc-723704-04072026Tue, 07 Apr 2026 00:00:00 +00007 Apr 2026. ProRx LLC. Compounding Pharmacy/Adulterated Drug Products. Center for Drug Evaluation and Research (CDER).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/formpour-722215-03312026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/formpour-722215-03312026Tue, 31 Mar 2026 00:00:00 +000031 Mar 2026. FormPour. Unapproved New Drugs Sold Over the Internet. Center for Drug Evaluation and Research (CDER).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gram-peptides-721806-03312026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gram-peptides-721806-03312026Tue, 31 Mar 2026 00:00:00 +000031 Mar 2026. Gram Peptides. Unapproved New Drugs Sold Over the Internet. Center for Drug Evaluation and Research (CDER). In our database: Gram Peptides.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangzhou-huli-technology-co-ltd-dba-fantasy-face-722228-03312026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangzhou-huli-technology-co-ltd-dba-fantasy-face-722228-03312026Tue, 31 Mar 2026 00:00:00 +000031 Mar 2026. Guangzhou Huli Technology Co., Ltd. dba Fantasy Face. Unapproved New Drugs Sold Over the Internet. Center for Drug Evaluation and Research (CDER).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lovega-llc-dba-pink-pony-peptides-721088-03312026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lovega-llc-dba-pink-pony-peptides-721088-03312026Tue, 31 Mar 2026 00:00:00 +000031 Mar 2026. Lovega LLC dba Pink Pony Peptides. Unapproved New Drugs Sold Over the Internet. Center for Drug Evaluation and Research (CDER). In our database: Pink Pony Peptides (Lovega LLC).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mile-high-compounds-llc-721600-03312026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mile-high-compounds-llc-721600-03312026Tue, 31 Mar 2026 00:00:00 +000031 Mar 2026. Mile High Compounds LLC. Unapproved New Drugs Sold Over the Internet. Center for Drug Evaluation and Research (CDER). In our database: Mile High Compounds LLC.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pekcura-labs-721709-03312026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pekcura-labs-721709-03312026Tue, 31 Mar 2026 00:00:00 +000031 Mar 2026. PekCura Labs. Unapproved New Drugs Sold Over the Internet. Center for Drug Evaluation and Research (CDER). In our database: PekCura Labs.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/prime-sciences-721805-03312026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/prime-sciences-721805-03312026Tue, 31 Mar 2026 00:00:00 +000031 Mar 2026. Prime Sciences. Unapproved New Drugs Sold Over the Internet. Center for Drug Evaluation and Research (CDER). In our database: Prime Sciences.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/24hrdoc-inc-dba-24hrdoc-717984-02202026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/24hrdoc-inc-dba-24hrdoc-717984-02202026Fri, 20 Feb 2026 00:00:00 +000020 Feb 2026. 24HrDoc, Inc. dba 24HrDoc. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: 24HrDoc (24hrdoc LLC).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/alan-health-technologies-inc-dba-alan-721814-02202026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/alan-health-technologies-inc-dba-alan-721814-02202026Fri, 20 Feb 2026 00:00:00 +000020 Feb 2026. Alan Health Technologies Inc. dba Alan. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Alan Meds.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aspen-aesthetics-dba-fifty-410-721481-02202026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aspen-aesthetics-dba-fifty-410-721481-02202026Fri, 20 Feb 2026 00:00:00 +000020 Feb 2026. Aspen Aesthetics dba Fifty 410. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Fifty 410 (Aspen Aesthetics).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/belle-health-llc-dba-belle-721795-02202026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/belle-health-llc-dba-belle-721795-02202026Fri, 20 Feb 2026 00:00:00 +000020 Feb 2026. Belle Health LLC dba Belle. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Belle.https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/better-health-labs-inc-dba-measured-721454-02202026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/better-health-labs-inc-dba-measured-721454-02202026Fri, 20 Feb 2026 00:00:00 +000020 Feb 2026. Better Health Labs, Inc. dba Measured. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Measured (Better Health Labs, Inc.).https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bliv-wellness-llc-dba-bliv-721479-02202026https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bliv-wellness-llc-dba-bliv-721479-02202026Fri, 20 Feb 2026 00:00:00 +000020 Feb 2026. Bliv Wellness LLC dba Bliv. False & Misleading Claims/Misbranded (Telehealth). Center for Drug Evaluation and Research (CDER). In our database: Bliv.